Taisuke Araki

8PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersIntensive careMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Condensed matter characterisation technique development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2024
Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study.

Ryota Ozawa, Kei Sonehara, Tsutomu Hachiya

|Jan 11, 2024
Practical Utility of a Clinical Pathway for Older Patients with Aspiration Pneumonia: A Single-Center Retrospective Observational Study.

Taisuke Araki, Yoshitaka Yamazaki, Masanobu Kimoto

|Jun 06, 2023
Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance.

Taisuke Araki, Shintaro Kanda, Hidehito Horinouchi

|Jan 13, 2023
C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study.

Kei Sonehara, Ryota Ozawa, Mineyuki Hama

|Oct 04, 2022
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size.

Sachie Koike, Kimihiro Shimizu, Shogo Ide

|May 26, 2022
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.

Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu

Pageof 2

Frequent Collaborators

5 joint publications

Kei Sonehara

3 joint publications

Kazunari Tateishi

2 joint publications

Shintaro Kanda

2 joint publications

Tomonobu Koizumi